PGHL.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 07:21):

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements...

Stats
Šios dienos apimtis	760.00
Vidutinė apimtis	21 597.00
Rinkos kapitalizacija	78.30B
EPS	INR0 ( 2024-02-05 )
Kita pelno data	( INR0 ) 2024-05-02
Last Dividend	INR45.00 ( 2023-02-13 )
Next Dividend	INR0 ( N/A )
P/E	34.52
ATR14	INR11.84 (0.25%)

Tūris Koreliacija

Ilgas: -0.08 (neutral)

Trumpas: -0.45 (neutral)

Signal:(42.189) Neutral

Procter & Gamble Health Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Procter & Gamble Health Koreliacija - Valiuta/Žaliavos

-0.24
( neutral )

0.06
( neutral )

-0.16
( neutral )

0.02
( neutral )

-0.27
( neutral )

0.15
( neutral )

Procter & Gamble Health Finansinės ataskaitos

Annual	2022
Pajamos:	INR12.30B
Bruto pelnas:	INR8.68B (70.57 %)
EPS:	INR138.24

FY	2022
Pajamos:	INR12.30B
Bruto pelnas:	INR8.68B (70.57 %)
EPS:	INR138.24

FY	2023
Pajamos:	INR0
Bruto pelnas:	INR0 (0.00 %)
EPS:	INR0

FY	2022
Pajamos:	INR10.92B
Bruto pelnas:	INR7.25B (66.38 %)
EPS:	INR116.00

Financial Reports:

No articles found.

Procter & Gamble Health Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR11.50 (N/A)	INR45.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Procter & Gamble Health Dividend Information - Dividend Junior

Dividend Sustainability Score: 7.44 - good (74.44%) | Divividend Growth Potential Score: 2.95 - Decrease likely (41.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR7.80	2003-05-12
Last Dividend	INR45.00	2023-02-13
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	23	--
Total Paid Out	INR1 058.30	--
Avg. Dividend % Per Year	0.95%	--
Score	2.67	--
Div. Sustainability Score	7.44
Div.Growth Potential Score	2.95
Div. Directional Score	5.20	--

Next Divdend (Est)
(2025-02-05)

INR0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.67

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR15.00	0.68%
2019	INR416.00	13.20%
2020	INR188.00	4.26%
2021	INR90.00	1.29%
2022	INR52.50	1.00%
2023	INR45.00	1.12%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SARDAEN.NS	Dividend Junior	2023-09-07	Annually	15	0.65%
MAGADSUGAR.NS	Dividend Junior	2023-07-13	Annually	7	1.78%
GMDCLTD.NS	Dividend Knight	2023-09-22	Annually	23	3.41%
ASTRAMICRO.NS	Dividend Junior	2023-08-23	Annually	20	0.49%
TITAN.NS	Dividend Junior	2023-07-13	Annually	20	0.35%
PETRONET.NS	Dividend Knight	2023-08-18	Semi-Annually	18	2.36%
JASH.NS	Dividend Junior	2023-09-22	Annually	7	0.57%
DBOL.NS	Dividend Junior	2023-06-23	Insufficient data to determine frequency	2	0.56%
SILINV.NS	Dividend Junior	2023-08-18	Annually	23	0.63%
MBAPL.NS	Dividend Junior	2023-09-18	Annually	8	0.44%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.183	1.500	6.34	9.50	[0 - 0.5]
returnOnAssetsTTM	0.210	1.200	2.99	3.58	[0 - 0.3]
returnOnEquityTTM	0.298	1.500	7.80	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.35	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.50	0.800	0.0153	0.0122	[0.8 - 2.5]
cashRatioTTM	1.846	1.500	0.854	1.281	[0.2 - 2]
debtRatioTTM	0.0100	-1.500	9.83	-10.00	[0 - 0.6]
interestCoverageTTM	405.00	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0.0134	-1.500	9.95	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.648	1.000	2.54	2.54	[0.2 - 0.8]
operatingProfitMarginTTM	0.246	1.000	7.09	7.09	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	1.149	0.800	5.68	4.54	[0.5 - 2]
Total Score				7.44

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	34.68	1.000	6.60	0	[1 - 100]
returnOnEquityTTM	0.298	2.50	8.59	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	5.28	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.461	1.500	3.59	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				2.95

Procter & Gamble Health

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.

Realaus laiko atnaujinimai Procter & Gamble Health [PGHL.NS]

Upcoming Earnings Alert

Procter & Gamble Health Dividend Information - Dividend Junior

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)